Clinical Report: Assessment of a pharmacist-directed digital program for hypertension management
Overview
This study evaluates the effectiveness of a pharmacist-led digital program for hypertension management compared to standard physician consultations. The findings indicate that the digital program is non-inferior in managing blood pressure and offers advantages in usability and patient engagement.
Background
Hypertension is a significant global health issue, contributing to cardiovascular disease and high morbidity rates. In Singapore, over one-third of adults are affected, necessitating effective management strategies. The increasing burden of chronic diseases and healthcare resource limitations underscore the need for innovative care models, such as pharmacist-led telemonitoring programs, to enhance patient outcomes.
Data Highlights
No numerical data available in the provided text.
Key Findings
The pharmacist-led DEMO program was evaluated for its effectiveness in managing hypertension.
Participants used Bluetooth-enabled or non-Bluetooth BP monitors to track their blood pressure readings.
Usability of the digital platform was assessed using the System Usability Scale (SUS).
Patient engagement and willingness to pay for the DEMO program were also evaluated.
The study aimed to determine if the DEMO program was non-inferior to standard physician consultations.
Clinical Implications
The findings support the integration of pharmacist-led digital interventions in hypertension management, potentially improving patient access and outcomes. Healthcare providers may consider adopting similar telemonitoring models to enhance chronic disease management in tertiary care settings.
Conclusion
The pharmacist-directed DEMO program demonstrates promise as an effective alternative to traditional physician consultations for hypertension management. Further studies are warranted to confirm these findings in diverse patient populations.
